Evidence map›Paper›PMID 34020657›Full record

ArticleGlobalization and health2021

Globalization, first-foods systems transformations and corporate power: a synthesis of literature and data on the market and political practices of the transnational baby food industry.

Phillip Baker, Katheryn Russ, Manho Kang, Thiago M Santos, Paulo A R Neves, Julie Smith, Gillian Kingston, Melissa Mialon, Mark Lawrence, Benjamin Wood and 5 more

Abstract read
In one paragraph

Article in Globalization and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biocultural Determinants of Mothers' Complementary Feeding Decisions in the Urban Brazilian Amazon.American journal of human biology : the official journal of the Human Biology Council · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Phillip BakerInstitute for Physical Activity and Nutrition, Deakin University, Geelong, Australia. phil.baker@deakin.edu.au.ORCID 0000-0002-0802-2349
Katheryn RussUniversity of California, Davis, CA, USA.
Manho KangUniversity of California, Davis, CA, USA.
Thiago M SantosInternational Centre for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Paulo A R NevesInternational Centre for Equity in Health, Federal University of Pelotas, Pelotas, Brazil.
Julie SmithResearch School of Population Health, Australian National University, Canberra, Australia.
Gillian KingstonCentre for Primary Care and Public Health, Queen Mary University, London, UK.
Melissa MialonTrinity Business School, Trinity College Dublin, Dublin, Ireland.
Mark LawrenceInstitute for Physical Activity and Nutrition, Deakin University, Geelong, Australia.
Benjamin WoodSchool of Health and Social Development, Deakin University, Geelong, Australia.
Rob MoodieMelbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
David ClarkIndependent Consultant on Public Health Law, New York, USA.
Katherine SievertSchool of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.
Monique BoatwrightSchool of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.
David McCoySchool of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global milk formula market has 'boomed' in recent decades, raising serious concerns for breastfeeding, and child and maternal health. Despite these developments, few studies have investigated the global expansion of the baby food industry, nor the market and political practices corporations have used to grow and sustain their markets. In this paper, our aim is to understand the strategies used by the baby food industry to shape 'first-foods systems' across its diverse markets, and in doing so, drive milk formula consumption on a global scale. We used a theoretically guided synthesis review method, which integrated diverse qualitative and quantitative data sources.

resultsGlobal milk formula sales grew from ~US$1.5 billion in 1978 to US$55.6 billion in 2019. This remarkable expansion has occurred along two main historical axes. First, the widening geographical reach of the baby food industry and its marketing practices, both globally and within countries, as corporations have pursued new growth opportunities, especially in the Global South. Second, the broadening of product ranges beyond infant formula, to include an array of follow-up, toddler and specialized formulas for a wider range of age groups and conditions, thereby widening the scope of mother-child populations subject to commodification. Sophisticated marketing techniques have been used to grow and sustain milk formula consumption, including marketing through health systems, mass-media and digital advertising, and novel product innovations backed by corporate science. To enable and sustain this marketing, the industry has engaged in diverse political practices to foster favourable policy, regulatory and knowledge environments. This has included lobbying international and national policy-makers, generating and deploying favourable science, leveraging global trade rules and adopting corporate policies to counter regulatory action by governments.

conclusionThe baby food industry uses integrated market and political strategies to shape first-foods systems in ways that drive and sustain milk formula market expansion, on a global scale. Such practices are a major impediment to global implementation of the International Code of Marketing of Breastmilk Substitutes, and other policy actions to protect, promote and support breastfeeding. New modalities of public health action are needed to negate the political practices of the industry in particular, and ultimately to constrain corporate power over the mother-child breastfeeding dyad.

Indexed as

Infant FormulaMilk, HumanBreast FeedingFemaleFood IndustryHumansInfantInternationalityBaby food industryBreastfeedingBreastmilk substitutesCommercial determinants of healthCorporate powerCorporate scienceFood systemsInfant formulaLobbyingMilk formula

Identifiers

PMID34020657
PMCPMC8139375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.